QuadMedicine, Inc. (KOSDAQ:464490)
South Korea
· Delayed Price · Currency is KRW 14,010
-320 (-2.23%)
At close: Apr 28, 2026
QuadMedicine Market Cap
QuadMedicine has a market cap or net worth of 160.86 billion as of April 28, 2026.
Market Cap
160.86B
Enterprise Value
140.83B
Revenue
10.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
14,010.00
Market Cap Chart
Since December 12, 2025, QuadMedicine's market cap has decreased from 199.95B to 160.86B, a decrease of -19.55%. That is a compound annual growth rate of -43.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 160.86B | -9.02% |
| Dec 30, 2025 | 176.81B | -11.57% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prestige Biologics | 185.83B |
| Ensol Biosciences | 186.26B |
| CORESTEMCHEMON | 141.73B |
| ISU Abxis | 202.63B |
| BIO-FD&C | 126.00B |
| Genome & Company | 221.57B |
| NovMetaPharma | 118.01B |
| ViGenCell | 229.80B |